Stock Track | Denali Therapeutics Soars 7.98% Pre-market on Sector Optimism After Biogen's Alzheimer's Therapy Advancement

Stock Track05-14

Denali Therapeutics Inc. (DNLI) saw its stock price surge 7.98% during pre-market trading on Thursday.

The sharp rise appears to be linked to positive sentiment in the Alzheimer's disease treatment sector. Biogen announced plans to advance its experimental Alzheimer's therapy, diranersen, to late-stage development after it showed promise in reducing tau protein buildup and demonstrated cognitive benefits in a mid-stage trial. As Denali Therapeutics also has an Alzheimer's treatment in development, investors reacted optimistically to the broader progress in the field.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1185625024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185625024","market":"us","top_or_hot":-1,"title":"Stock Track | Denali Therapeutics Soars 7.98% Pre-market on Sector Optimism After Biogen's Alzheimer's Therapy Advancement","media":"Stock Track","content":"<p>Denali Therapeutics Inc. (DNLI) saw its stock price surge 7.98% during pre-market trading on Thursday.</p><p>The sharp rise appears to be linked to positive sentiment in the Alzheimer's disease treatment sector. Biogen announced plans to advance its experimental Alzheimer's therapy, diranersen, to late-stage development after it showed promise in reducing tau protein buildup and demonstrated cognitive benefits in a mid-stage trial. As Denali Therapeutics also has an Alzheimer's treatment in development, investors reacted optimistically to the broader progress in the field.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Denali Therapeutics Soars 7.98% Pre-market on Sector Optimism After Biogen's Alzheimer's Therapy Advancement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Denali Therapeutics Soars 7.98% Pre-market on Sector Optimism After Biogen's Alzheimer's Therapy Advancement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 19:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Denali Therapeutics Inc. (DNLI) saw its stock price surge 7.98% during pre-market trading on Thursday.</p><p>The sharp rise appears to be linked to positive sentiment in the Alzheimer's disease treatment sector. Biogen announced plans to advance its experimental Alzheimer's therapy, diranersen, to late-stage development after it showed promise in reducing tau protein buildup and demonstrated cognitive benefits in a mid-stage trial. As Denali Therapeutics also has an Alzheimer's treatment in development, investors reacted optimistically to the broader progress in the field.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DNLI","symbol_name":"Denali Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1185625024","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185625024","pubTimestamp":1778758626,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Denali Therapeutics Inc. (DNLI) saw its stock price surge 7.98% during pre-market trading on Thursday.The sharp rise appears to be linked to positive sentiment in the Alzheimer's disease treatment...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DNLI":"Denali Therapeutics Inc."},"translate_title":"个股追踪|Denali Therapeutics盘前飙升7.98%，因百健(Biogen)阿尔茨海默病疗法取得进展后板块乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DNLI":1},"content_text":"Denali Therapeutics Inc. (DNLI) saw its stock price surge 7.98% during pre-market trading on Thursday.The sharp rise appears to be linked to positive sentiment in the Alzheimer's disease treatment sector. Biogen announced plans to advance its experimental Alzheimer's therapy, diranersen, to late-stage development after it showed promise in reducing tau protein buildup and demonstrated cognitive benefits in a mid-stage trial. As Denali Therapeutics also has an Alzheimer's treatment in development, investors reacted optimistically to the broader progress in the field.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1185625024","isCrawlerRequest":true}